 ProPhase Labs has expanded its in-house testing capabilities for the diagnostics of the new clinical chemistry, immunoassay, hematology, hemostasis, and urinalysis analyzers. ProPhase Labs has successfully obtained rights to commercialize two patented small molecule PIM kinase inhibitors in the licensing agreement with Global BioLife, Inc. 